A Candidate who has passed B.Pharm degree examination of Rajiv Gandhi University of Health Sciences, or B.Pharm examination of any other Indian University established by law in India or any other degree courses in Pharmacy recognized as equivalent by RGUHS or Pharmacy Council of India (PCI) and/or All India Council of Technical Education (AICTE) for this purpose and who has secured not less than 55% of the maximum marks (aggregate of 4 years) prescribed for the qualifying examination will be eligible for admission to the M.Pharm course.

For SC/ST Category-I Candidates, the prescribed percentage of marks will be 50% of the maximum marks in the qualifying examinations.

Further, Pharmacy teachers having recognized B.Pharm qualification and with minimum of 5 years of teaching experience in an institution approved by AICTE and PCI will be eligible provided they have scored not less than 50% of the maximum marks (Aggregate of 4 years).

The course of study including submission of a dissertation on the research project assigned will be of 24 months (2 years) duration from the commencement of academic term.

The curriculum of M.Pharm is of annual system that includes M.Pharm Part I extending for 12 months from the commencement of the academic term and M.Pharm Part II of 12 months duration.

At the end of M.Pharm Part I there shall be a university examination for the same. At the end of M.Pharm Part II, the candidate shall submit a dissertation on project work approved by the University.

During the course of study, candidates of M.Pharm Part-I will undergo a compulsory course in Modern Pharmaceutical Analysis common to all branches of specialization (except in Pharmacy Practice Branch Marketing and Management Branch where the student will study a course in Pharmacology and Therapeutics) and a course of 3 ELECTIVES offered by the institution. The various subjects of specializations are shown below.

Pharmacology
Pharmacy Practice
Pharmaceutics

Candidate who has put in a minimum of 80% of attendance in all the theory and practical assignments separately will be permitted to appear for M.Pharm Part-I examination. The Vice-Chancellor of the university shall, however condone shortage of attendance to an extent of 10 percent on the recommendation of the Principal.

There will be an examination for M.Pharm Part-I at the end of one calendar year. For M.Pharm Part-II the examination will be an evaluation of dissertation and viva voce at the end of 12 months after the completion of M.Pharm Part-I examination.

There will be a minimum of two sessional tests in each subjects of specialization conducted at regular intervals at the end of first term and second term respectively, both in theory and practical which include seminars.

The sessional marks will be awarded out of a maximum of 50 in theory and practical as follows:

Theory
a) Written Test : 30 Marks (average of two)
b) Seminar : 20 Marks
c) Total : 50 Marks

Practical
a) Practical Test : 30 Marks
b) Laboratory Work : 20 Marks

B. Annual Examination (Part-I): There Shall be 4 theory papers in the final examination. Each paper will be of 3 hours duration carrying 100 marks in each of the subjects. A candidate has to secure minimum of 40% marks (excluding internals) in theory and practical separately for passing the examination.

Candidates who fails in theory or practical exam in a subject, shall appear for both theory and pratical in the subsequent examination in that subject.

A candidate who has secured 50% of the maximum marks in each subject in theory and practical separately including sessional marks and annual examination marks together will be declared to have passed in M.Pharm Part-I examination. Those candidates who fail in one or more subjects will have to appear only for the subjects failed in the subsequent examinations.

Candidates who fail in M.Pharm part-I examination will be permitted to register for M.Pharm Part-II course. However, such a candidate will not be permitted to submit the dissertation unless the candidate completes the M.Pharm Part-I examination and passes both in theory and practical together.

M.Pharm Part-II will consist of submitting a dissertation written on the regular research project carried out during the second year by the candidate under the supervision of a guide. A guide will be a full time postgraduate teacher of the institution who is recognized by Rajiv Gandhi University of Health Sciences. However, a co-guide can be adopted wherever required.

Three copies of the dissertation duly certified by the guide and the Principal must be submitted by the candidate to the University either in printed or typed or in bound form, through the Principal on or before the prescribed date.

The Oral (Viva-Voce) Examination will be held after the submission of dissertation. If any candidate fails to submit the dissertation on or before the date prescribed, his/her Viva-Voce will be conducted during the subsequent examination, which will not be earlier than 6 months from the date fixed in the first instance.

The minimum percentage of marks for final passing has to be 50% of the total allotted marks of 200 for M.Pharm Part-II (150 Marks dissertation work and 50 Marks for Viva Voce will be decided by both examiners).

Class shall be declared on the basis of the aggregate of marks scored in M.Pharm Part-I and Part-II as follows.

1. 75% and above-Distinction
2. 60% & above but less than 75% - First Class
3. 50% & above but less than 60% - Second Class
4. Less than 50% - Fail

The candidate cannot take more than 4 years to complete the course.